Patent assignee · US · COMPANY

NANOSPHERE, INC.

🏢 View company profile →
62Patents
11Active
62Granted
41Portfolio score

Filing activity: Jun 25, 1999 → Sep 12, 2018 · 9 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US6361944B1 Nanoparticles having oligonucleotides attached thereto and uses therefor Chemistry; Metallurgy 368 Expired
US6974669B2 Bio-barcodes based on oligonucleotide-modified nanoparticles Emerging Cross-Sectional Technologies 212 Expired
US6506564B1 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 202 Expired
US6750016B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 135 Expired
US6767702B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 134 Expired
US6417340B1 Nanoparticles having oligonucleotides attached thereto and uses therefor Chemistry; Metallurgy 123 Expired
US6582921B2 Nanoparticles having oligonucleotides attached thereto and uses thereof Emerging Cross-Sectional Technologies 95 Expired
US6720411B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 88 Expired
US6682895B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 79 Expired
US6610491B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 75 Expired
US6495324B1 Nanoparticles having oligonucleotides attached thereto and uses therefor Chemistry; Metallurgy 74 Expired
US6773884B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 73 Expired
US6777186B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 69 Expired
US6759199B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 68 Expired
US6677122B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 66 Expired
US6709825B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 64 Expired
US7250499B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 58 Expired
US6645721B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 53 Expired
US6730269B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 50 Expired
US6812334B1 Nanoparticles having oligonucleotides attached thereto and uses therefor Chemistry; Metallurgy 49 Expired
US7098320B1 Nanoparticles having oligonucleotides attached thereto and uses therefor Chemistry; Metallurgy 48 Expired
US6673548B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 48 Expired
US7169556B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 47 Expired
US6406745B1 Methods for coating particles and particles produced thereby Chemistry; Metallurgy 47 Expired
US6720147B2 Nanoparticles having oligonucleotides attached thereto and uses therefor Emerging Cross-Sectional Technologies 45 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.